Status:
TERMINATED
Biological Imaging for Optimising Clinical Target Volume (CTV) and Gross Tumour Volume (GTV) Contouring in Prostate Cancer to Improve the Possibilities for Intensity Modulated RadioTherapy (IMRT) Dose Escalation
Lead Sponsor:
Alberta Health services
Conditions:
Prostate Cancer
Eligibility:
MALE
Brief Summary
The clinical outcome after external beam irradiation for prostate cancer is disappointing in the advanced tumor stages. There are indications that an increase in radiation dose to the tumor will impro...
Detailed Description
Proposal: To investigate the possibilities to improve Clinical Target Volume (CTV) and Gross Tumour Volume (GTV) delineation by using the latest biological imaging modalities on 15 patients with pros...
Eligibility Criteria
Inclusion
- Histologically proven prostate adenocarcinoma
Exclusion
- Previous treatment for prostate cancer
- Contraindications to magnetic resonance imaging (MRI)
Key Trial Info
Start Date :
May 1 2004
Trial Type :
OBSERVATIONAL
End Date :
February 1 2007
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00122252
Start Date
May 1 2004
End Date
February 1 2007
Last Update
December 9 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2